Medical students should consider how AI could change the work physicians do (and get paid for) when choosing specialties.
You can’t help chuckling at the irony. The man who made millions from making the world laugh failed to convince an audience ...
Conservative pundit George Will, a self-described Ronald Reagan Republican, has little good to say about the Presidential ...
Eli Lilly and Company reported third quarter results and missed expectations and had to lower its guidance, which was a huge disappointment for investors. But in the last few years, Eli Lilly was ...
Jennifer Hudson as Whitney Houston in 'The Bodyguard' from the Halloween episode of 'The Jennifer Hudson Show' Jennifer Hudson is paying tribute to one of the greats this Halloween. For the third ...
Eli Lilly’s third-quarter sales and earnings were lower than expected, a rare stumble for the company that had consistently reported strong sales and beat earnings forecasts since demand for its ...
“We felt like we needed to expand to do a better job, a timelier job of ginning the producer’s cotton,” said Jerrell Key, general manager for Adobe Walls. “We jumped in and built another gin.
A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.
The industry body representing Australian cotton growers has called for continuity in the regulation of the controversial chemical paraquat. Paraquat is a widely used weedkiller that has been ...
Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...
Whitney Leavitt, one of the stars from “The Secret Lives of Mormon Wives,” has welcomed a baby boy! Leavitt, who is already the mom of two young children (Sedona, 4, and Liam, 2), shared on ...
Also Read: Eli Lilly’s Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron’s Dupixent In the LUCENT-3 trial, mirikizumab helped patients ...